Medtronic Investors Win Cert. In Off-Label Marketing Case
A Minnesota federal judge on Monday granted class certification to a group of shareholders alleging Medtronic Inc.'s stock value plunged because the company promoted off-label uses for its Infuse spinal graft...To view the full article, register now.
Already a subscriber? Click here to view full article